ADVFN ADVFN

Hot Features

Icon for default 登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。
ContraFect Corporation (EM)

ContraFect Corporation (EM) (CFRXQ)

0.000001
0.00
( 0.00% )
更新日時: 09:00:00

ContraFect Corporation (EM) (CFRXQ) 銘柄情報

ポートフォリオを強化: リアルタイムのディスカッションと実用的な取引アイデア。

プレミアム

主要統計と詳細

通貨
0.000001
( - )
買値
0.00
売値
0.00
出来高
1
平均取引量 (3 か月)
US$ 664
財務取引量
-
0.00 日の範囲 0.00
0.000001 52 週間の範囲 0.0005
時価総額
企業価値
-
前日終値
0.000001
始値
-
最終取引時間
22:54:29
VWAP
-
歳入
-
純利益
-24.14M
発行済株式数
10,704,803
浮動株比率 (%)
-
機関投資家保有比率 (%)
0.00%
配当利回り
PER
-
株価売上高倍率 (PSR)
-
1 株当たり利益 (EPS)
-5.58
ベータ
-10.2

ContraFect Corporation (EM) について

ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clin... ContraFect Corporation, a clinical-stage biotechnology company, discovers and develops therapeutic protein and antibody products for the treatment of life-threatening and drug-resistant infectious diseases in the United States. Its lead program includes Exebacase, a lysin, which is in Phase III clinical trials for the treatment of staphylococcus aureus. The company also developing CF-370, an investigational anti-bacterial therapeutic candidate, which is in Phase 1 clinical trials to treat pseudomonas aeruginosa infections, such as ventilator associated pneumonia, blood stream infections, complicated urinary tract infections, and surgery carry infections. It also developing CF-296, an osteomyelitis and PJI which is in preclinical trailers for the treatment of joint infections. In addition, the company developing Exebacase for the treatment of persistent bacteremia caused by methicillin-resistant staphylococcus aureus in COVID-19 patients. Further, It develops CF-296, an engineered lysin, used for treatment of the invasive infections caused by staphylococcus aureus including biofilm-related infections in prosthetic joints and indwelling devices and osteomyelitis. The company has a license agreement with The Rockefeller University to identify novel lysin therapeutic candidates targeting gram-negative pathogens. ContraFect Corporation was incorporated in 2008 and is headquartered in Yonkers, New York. On December 4, 2023, ContraFect Corporation filed a voluntary petition for liquidation under Chapter 7 in the U.S. Bankruptcy Court for the District of Delaware. 詳細を表示

セクター
Healthcare
業界
Biotechnology & Life Sciences
ウェブサイト
本社
Yonkers, United States
設立
2026
ContraFect Corporation (EM) is listed in the Healthcare sector of the その他OTC with ticker CFRXQ. The last closing price for ContraFect (EM) was US$0. Over the last year, ContraFect (EM) shares have traded in a share price range of US$ 0.000001 to US$ 0.0005.

ContraFect (EM) currently has 10,704,803 shares in issue. The market capitalisation of ContraFect (EM) is US$10.70 . ContraFect (EM) has a price to earnings ratio (PE ratio) of 0.

CFRXQ 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10000000CS
4001.0E-61.0E-61.0E-63371.0E-6CS
12001.0E-61.0E-61.0E-63731.0E-6CS
26-9.0E-6-901.0E-51.0E-51.0E-617881.0E-6CS
52-0.000499-99.80.00050.00051.0E-6139629.719E-5CS
156-0.044999-99.99777777780.0450.141.0E-6228270.02083712CS
260-0.044999-99.99777777780.0450.141.0E-6228270.02083712CS

CFRXQ - Frequently Asked Questions (FAQ)

What is the current ContraFect Corporation (EM) share price?
The current share price of ContraFect Corporation (EM) is US$ 0.000001
How many ContraFect Corporation (EM) shares are in issue?
ContraFect Corporation (EM) has 10,704,803 shares in issue
What is the market cap of ContraFect Corporation (EM)?
The market capitalisation of ContraFect Corporation (EM) is USD 10.7
What is the 1 year trading range for ContraFect Corporation (EM) share price?
ContraFect Corporation (EM) has traded in the range of US$ 0.000001 to US$ 0.0005 during the past year
What is the registered address of ContraFect Corporation (EM)?
The registered address for ContraFect Corporation (EM) is 28 Wells Avenue, Yonkers, New York, 10701
What is the ContraFect Corporation (EM) website address?
The website address for ContraFect Corporation (EM) is www.contrafect.com
Which industry sector does ContraFect Corporation (EM) operate in?
ContraFect Corporation (EM) operates in the Biotechnology & Life Sciences sector

CFRXQ 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

CFRXQ Discussion

投稿を表示